Inovio Wins $71 Million Department of Defense Contract for Its COVID-19 Vaccine Delivery DevicesThe Motley Fool • 06/23/20
INOVIO Receives $71 Million Contract From U.S. Department of Defense To Scale Up Manufacture of CELLECTRA® 3PSP Smart Device and Procurement of CELLECTRA® 2000 for COVID-19 DNA VaccinePRNewsWire • 06/23/20
Inovio Faces Shareholder Lawsuit Over 3-Hour Coronavirus Vaccine Claim, Company Says DNA Medicine MisunderstoodBenzinga • 06/16/20
Early Coronavirus Vaccines Likely To Target Further Complications, Not Infection, Health Experts SayBenzinga • 06/15/20
INOVIO and IVI Partner with Seoul National University Hospital to Start Phase 1/2 Clinical Trial of INOVIO's COVID-19 DNA Vaccine (INO-4800) in South KoreaPRNewsWire • 06/04/20